logo
NasdaqGM:IVVD logo

Invivyd Community

NasdaqGM:IVVD Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 65 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

IVVD logo
Invivyd
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts

Pemivibart And Next-Generation VYD2311 Will Empower Market Expansion By 2025

Key Takeaways The development of next-generation antibodies could expand market reach and improve margins by lowering production and administration costs. Efforts to engage with the scientific community and regulators may restore trust, enhancing future earnings and market potential.
View narrative
US$6.60
FV
91.1% undervalued intrinsic discount
173.47%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
32users have followed this narrative
7 days ago author updated this narrative